Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 2/Phase 3 study from the University of Chicago evaluating memantine in combination with behavioral treatment for Skin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Namenda (memantine)

Snippet

Sponsor: University of Chicago | Conditions: Skin-Picking, Trichotillomania (Hair-Pulling Disorder) | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING